A-778193
| A-778193_structure.png | |
A-778193 is a chemical compound that acts as a potent and selective CB2 receptor agonist. It was developed by Abbott Laboratories and has been used in scientific research to investigate the role of the CB2 receptor in various physiological processes.
Pharmacology[edit | edit source]
A-778193 is known for its high affinity and selectivity for the CB2 receptor, which is primarily expressed in the immune system. Unlike the CB1 receptor, which is predominantly found in the central nervous system, the CB2 receptor is involved in modulating immune responses and inflammation.
Mechanism of Action[edit | edit source]
A-778193 binds to the CB2 receptor, activating it and leading to a cascade of intracellular events that result in anti-inflammatory and immunomodulatory effects. This makes it a compound of interest for potential therapeutic applications in conditions such as autoimmune diseases, inflammatory disorders, and pain management.
Therapeutic Potential[edit | edit source]
Due to its selective action on the CB2 receptor, A-778193 has been studied for its potential to treat conditions without the psychoactive effects associated with CB1 receptor activation. Research has shown that CB2 receptor agonists like A-778193 can reduce inflammation and pain in animal models, suggesting potential applications in rheumatoid arthritis, multiple sclerosis, and other inflammatory conditions.
Research and Development[edit | edit source]
A-778193 has been primarily used in preclinical studies to explore the therapeutic potential of CB2 receptor agonists. These studies have provided insights into the role of the CB2 receptor in immune regulation and its potential as a target for new anti-inflammatory drugs.
Safety and Toxicology[edit | edit source]
As with many research compounds, the safety profile of A-778193 in humans is not well-established. Preclinical studies in animals have not shown significant adverse effects at therapeutic doses, but further research is needed to fully understand its safety and efficacy in humans.
Also see[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
